Meet the Executive Management Team

Our Executive Management Team, with decades of experience in drug discovery, clinical research, pharmaceutical manufacturing, and business administration, oversees business growth, sets strategic direction, and manages daily operations.

  • Rolf Sass Sørensen, MSc

    Chief Executive Officer

    Rolf brings more than 30 years of professional experience, including senior roles in investor relations and corporate communications at Bavarian Nordic. At TETRAPHARM, he leads the company’s strategic direction and business development, connecting scientific innovation with commercial opportunities and long-term value creation.

    LinkedIn

  • Morten Allesø, PhD

    Chief Scientific Officer

    Morten joined TETRAPHARM in January 2022. He brings more than 15 years of experience from the pharmaceutical industry, having held roles at Novo Nordisk, Lundbeck, and NNE as researcher in drug formulation development, and lead product and process development scientist.

    LinkedIn

  • Jens Mikkelsen, MD PhD

    Chief Development Officer

    Jens is professor at the University of Copenhagen in translational neuropharmacology, and an experienced researcher with an extensive publication record of more than 300 scientific publications and patents. In addition, Jens has more than 20 years of management experience from the pharmaceutical industry, and he has been involved in bringing several novel drug candidates from early discovery phase to patients.

    LinkedIn

  • Ulrich Venge, MSc

    Chief Financial Officer

    Ulrich brings extensive experience from international finance leadership roles, with a strong track record in scaling organizations, driving financial transformation, and supporting strategic growth initiatives.

    LinkedIn

  • Henrik Lundorff, EMBA

    Chief Commercial Officer

    Henrik brings extensive executive experience from complex, people-driven organizations, including leadership roles at SAS and KidsAid. At TETRAPHARM, he leads the commercial strategy, partnerships, and market engagement, translating the company’s scientific platform into scalable business opportunities.

    He plays a key role in driving growth and positioning TETRAPHARM as a trusted partner across both CDMO services and its proprietary pipeline.

    LinkedIn

  • Jacob Schlundt

    Chief Marketing Officer

    Jacob joined TETRAPHARM in May 2023. He has extensive knowledge and experience in marketing, communication, and event planning, having held leadership positions with Aon and FLSmidth.

    LinkedIn